The 74 rating InvestorsObserver gives to Halozyme Therapeutics, Inc. (HALO) stock puts it near the middle of the Healthcare sector. In addition to scoring higher than 64 percent of stocks in the Healthcare sector, HALO’s 74 overall rating means the stock scores better than 74 of all stocks.
HALO has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on HALO!